The landscape of gynecological oncology has reached a significant milestone following the presentation of pivotal clinical trial data at the…
Read More
Navigating the Critical Transition from Laboratory Bench to GMP Fill-Finish CDMO Operations
The transition of a breakthrough therapeutic compound from an exploratory research laboratory to a clinical-grade Good Manufacturing Practice (GMP) environment…
Read More
ESMO 2026 Data Backs First-Line Orpathys Use in NSCLC Subgroup, But Adverse Events Temper Reaction
Recent clinical findings presented at the European Society for Medical Oncology (ESMO) Congress have shed new light on the therapeutic…
Read More
ESMO 2026: GSKs mo rez seeks an edge in a crowded adc field in ovarian cancer
The modern therapeutic landscape for advanced ovarian cancer is undergoing a profound structural evolution, driven largely by the clinical maturation…
Read More
ESMO 2026 Oral Cell Cycle Inhibitors Place Cyclin E1 as New Target in Oncology and Precision Medicine
The landscape of targeted cancer therapy is undergoing a significant paradigm shift following recent clinical disclosures at the European Society…
Read More
Gilead Sciences Secures Global Rights to PepStar’s Oral IL-23 Receptor Inhibitor HCXT-2001 in Landmark $1.275bn Agreement
Gilead Sciences has significantly expanded its footprint in the immunology and inflammatory bowel disease (IBD) therapeutic landscapes through a multi-billion-dollar…
Read More
Egypt Reforms Obsolete Pharmaceutical Pricing Framework to Revitalize Domestic Healthcare Sector and Secure Essential Drug Supplies
Egypt has officially undertaken a comprehensive overhaul of its decades-old pharmaceutical pricing framework, a decisive policy shift designed to resolve…
Read More
CPHI 2026 Preview: Pharma Manufacturing Puts AI to Work
Artificial intelligence is no longer a peripheral experiment in the pharmaceutical sector; as industry leaders prepare for CPHI 2026, the…
Read More
FDA Approves Cosette Pharmaceuticals Evoxac Oral Solution for Sjögren’s Disease Dry Mouth
Cosette Pharmaceuticals has secured a significant regulatory milestone with the United States Food and Drug Administration (FDA) granting approval for…
Read More
The Hidden Costs of Supplier Sprawl: Why Pharmaceutical Supply Chains Are Moving Toward Consolidation
For decades, the standard playbook for pharmaceutical procurement departments was built on the premise of diversification. As companies launched new…
Read More
